 | Up a level |
Pagani, O.; Sessa, C.; Nolè, F.; Crivellari, D.; Lombardi, D.; Thürlimann, B.; Hess, D.; Borner, M.; Bauer, J.; Martinelli, G.; Graffeo, R.; Zucchetti, M.; D'Incalci, M.; Goldhirsch, A. (2000). Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study. Annals of oncology, 11(8), pp. 985-991. Oxford University Press 10.1023/A:1008392927656
Sessa, C.; Minoia, C.; Ronchi, A.; Zucchetti, M.; Bauer, J.; Borner, M.; De Jong, J.; Pagani, O.; Renard, J.; Weil, C.; D'Lncalci, M. (1998). Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days. Annals of oncology, 9(12), pp. 1315-1322. Oxford University Press 10.1023/A:1008441416790
